Susceptibility of Diabetic Patients to COVID-19 Infections: Clinico-Hematological and Complications Analysis
- PMID: 36992148
- PMCID: PMC10056589
- DOI: 10.3390/vaccines11030561
Susceptibility of Diabetic Patients to COVID-19 Infections: Clinico-Hematological and Complications Analysis
Abstract
Background: Coronavirus disease 2019 has become a global health threat resulting in a catastrophic spread and more than 3.8 million deaths worldwide. It has been suggested that there is a negative influence of diabetes mellites (DM), which is a complex chronic disease, on COVID-19 severe outcomes. Other factors in diabetic patients may also contribute to COVID-19 disease outcomes, such as older age, obesity, hyperglycaemia, hypertension, and other chronic conditions.
Methods: A cohort study was conducted on the demographics, clinical information, and laboratory findings of the hospitalised COVID-19 with DM and non-DM patients were obtained from the medical records in King Faisal Specialist Hospital and Research Centre, Saudi Arabia.
Results: Among the study population, 108 patients had DM, and 433 were non-DM patients. Patients with DM were more likely to present symptoms such as fever (50.48%), anorexia (19.51%), dry cough (47.96%), shortness of breath (35.29%), chest pain (16.49%), and other symptoms. There was a significant decrease in the mean of haematological and biochemical parameters, such as haemoglobin, calcium, and alkaline phosphate in people with diabetes compared to non-diabetics and a considerable increase in other parameters, such as glucose, potassium, and cardiac troponin.
Conclusions: According to the findings of this study, patients who have diabetes have a greater risk of developing more severe symptoms associated with COVID-19 disease. This could result in more patients being admitted to the intensive care unit as well as higher mortality rates.
Keywords: COVID-19; Saudi Arabia; diabetics; susceptibility.
Conflict of interest statement
The authors declare that there are no conflicts of interest regarding the publication of this paper.
Similar articles
-
Clinical and laboratory profile and outcomes of hospitalized COVID-19 patients with type 2 diabetes mellitus in Ghana - A single-center study.Endocrinol Diabetes Metab. 2023 Jan;6(1):e391. doi: 10.1002/edm2.391. Epub 2022 Nov 25. Endocrinol Diabetes Metab. 2023. PMID: 36426913 Free PMC article.
-
Susceptibility of ABO blood group to COVID-19 infections: clinico-hematological, radiological, and complications analysis.Medicine (Baltimore). 2021 Dec 30;100(52):e28334. doi: 10.1097/MD.0000000000028334. Medicine (Baltimore). 2021. PMID: 34967364 Free PMC article.
-
Diabetes and Covid-19 among hospitalized patients in Saudi Arabia: a single-centre retrospective study.Cardiovasc Diabetol. 2020 Dec 5;19(1):205. doi: 10.1186/s12933-020-01184-4. Cardiovasc Diabetol. 2020. PMID: 33278893 Free PMC article.
-
Pathophysiology, Transmission, Diagnosis, and Treatment of Coronavirus Disease 2019 (COVID-19): A Review.JAMA. 2020 Aug 25;324(8):782-793. doi: 10.1001/jama.2020.12839. JAMA. 2020. PMID: 32648899 Review.
-
Clinical Characteristics and Morbidity Associated With Coronavirus Disease 2019 in a Series of Patients in Metropolitan Detroit.JAMA Netw Open. 2020 Jun 1;3(6):e2012270. doi: 10.1001/jamanetworkopen.2020.12270. JAMA Netw Open. 2020. PMID: 32543702 Free PMC article. Review.
Cited by
-
The Role of Glycemic Control in Inflammation Markers and Clinical Outcomes in Type 2 Diabetes Patients with Severe COVID-19.Biomedicines. 2025 Apr 6;13(4):886. doi: 10.3390/biomedicines13040886. Biomedicines. 2025. PMID: 40299484 Free PMC article.
-
The resident gut microbiome modulates the effect of synbiotics on the immunogenicity after SARS-COV-2 vaccination in elderly and diabetes patients.NPJ Biofilms Microbiomes. 2025 Aug 25;11(1):171. doi: 10.1038/s41522-025-00804-9. NPJ Biofilms Microbiomes. 2025. PMID: 40851072
-
Type 2 diabetes mellitus as a predictor of severe outcomes in COVID-19 - a systematic review and meta-analyses.BMC Infect Dis. 2025 May 19;25(1):719. doi: 10.1186/s12879-025-11089-w. BMC Infect Dis. 2025. PMID: 40389865 Free PMC article.
-
A Review on Risk Factors, Traditional Diagnostic Techniques, and Biomarkers for Pneumonia Prognostication and Management in Diabetic Patients.Diseases. 2024 Dec 2;12(12):310. doi: 10.3390/diseases12120310. Diseases. 2024. PMID: 39727640 Free PMC article. Review.
-
Prognostic Utility of dNLR, ALRI, APRI, and SII in COVID-19 Patients with Diabetes: A Cross-Sectional Study.Diagnostics (Basel). 2024 Aug 4;14(15):1685. doi: 10.3390/diagnostics14151685. Diagnostics (Basel). 2024. PMID: 39125561 Free PMC article.
References
-
- World Health Organization Severe Acute Respiratory Syndrome. [(accessed on 13 November 2021)]. Available online: https://www.who.int/health-topics/severe-acute-respiratory-syndrome#tab=....
-
- Centers for Disease Control and Prevention SARS. [(accessed on 13 November 2021)]; Available online: https://www.cdc.gov/sars/about/faq.html.
-
- Saudi Center for Disease Prevention and Control-Daily Updates—Public Health Authority 2021. [(accessed on 13 November 2021)]; Available online: https://covid19.cdc.gov.sa/daily-updates/
LinkOut - more resources
Full Text Sources